Cost
What ibogaine treatment actually costs, what drives the price, and why the cheapest option is usually the most expensive decision you can make.
The ranges
These are the bands programmes advertised between 2024 and 2026. Prices move, and they are set by each provider rather than by any schedule, so treat the table as orientation and confirm the current figure directly with whoever you are talking to.
| Tier | Typical price (USD) | What it usually means |
|---|---|---|
| Budget / underground | Under $4,000 | Minimal medical infrastructure — the savings come out of screening and monitoring |
| Clinic standard | $5,000–$10,000 | Multi-day programme: physician screening, cardiac monitoring, nursing, basic aftercare |
| Premium / residential | $10,000–$25,000+ | Higher staffing ratios, longer stays, structured integration, extended follow-up |
We do not publish named clinic prices. A quoted price goes out of date quickly, it rarely covers the same things from one provider to the next, and a treatment website is not a source we would cite for anything else on this site. What follows is what the published medical protocols actually require, which is the part you can hold a quote against.
What you are actually paying for
Medical screening
A 12-lead ECG, blood count and metabolic panel, and physician review before you are accepted.
Supervision
Physician oversight, nursing, and continuous cardiac telemetry through the session and well beyond it.
Time & medicine
Several days of care, using tested pharmaceutical-grade ibogaine with a certificate of analysis.
Aftercare
Integration sessions and follow-up — the one element with any supporting outcome data.
What the protocols require, and what it costs to provide
Each line below is a real cost, and each is specified in a published study rather than invented by a clinic's marketing. This is the list to price a quote against.
| Requirement | Where it comes from |
|---|---|
| 12-lead ECG, safety bloodwork and physical exam before acceptance | A 191-person inpatient series screened exactly this way (Mash 2018) |
| Potassium and magnesium checked and corrected before dosing | Required within a defined range in a monitored series; low electrolytes raise arrhythmia risk independently (Knuijver 2022) |
| Continuous telemetry from before dosing to at least 24 hours after | Run from one hour before to 24 hours after in the 191-person series (Mash 2018); a prolonged QT interval persisted past 24 hours in 6 of 14 closely screened patients (Knuijver 2022) |
| Monitoring to 72 hours, and physical assistance throughout | The most cautious published protocol monitored for 72 hours; every patient in one series was temporarily unable to walk unaided (Cherian 2024) |
| Supervised medication washout before arrival | Eight categories of medicine were withdrawn before dosing, including CYP2D6 inhibitors, beta blockers and all psychiatric medication (Cherian 2024) |
| CYP2D6 genotyping, or a halved dose for poor metabolisers | Recommended by the authors who measured the interaction; genotype alone drives a more than tenfold spread in clearance (Glue 2015) |
| Physicians on site, IV fluids and electrolytes, resuscitation capability | Documented at a residential clinic treating 88 surveyed patients (Davis 2017) |
When a price looks too good, ask which of those seven is missing. The answer is almost always monitoring hours and pre-dosing screening — which is another way of saying "the safety". Genotyping and 72-hour telemetry are the first things to disappear from a cheap quote, and they are the two that address the risk that actually kills people.
Budget beyond the programme fee
- Travel — flights and, for most nationalities, an international trip
- Preparation — the medication washout is a supervised medical procedure, not an instruction to stop taking tablets, and stopping psychiatric medicine or benzodiazepines carries its own risk
- Extra nights — the insomnia after a dose often runs about 72 hours, so plan not to be travelling the next day
- Aftercare at home — therapy or coaching in the months after; give it a budget line from day one
- Insurance — the FDA has approved three medications for opioid use disorder, and ibogaine is not among them, so coverage is essentially nonexistent; assume self-funding
Treat aggressive financing pressure like any other high-pressure sales tactic — as a red flag. The full list: Choosing a Provider.
On aftercare being worth paying for. The cohort reporting the longest abstinence combined ibogaine with psychotherapy and reported a median of 5.5 months after one treatment and 8.4 after repeat treatment. That study was retrospective with no control group and cannot separate the therapy from the drug, so read it as the best available argument rather than a settled one.
Sources
Last reviewed October 2026. Price bands are observed advertised ranges, not a survey, and no clinic pricing page is cited as a source anywhere on this site.
- Screening and 24-hour telemetry: Mash, Duque, Page & Allen-Ferdinand 2018, Front Pharmacol 9:529 (full text)
- Electrolyte limits and QT persisting past 24 hours: Knuijver et al. 2022, Addiction 117(1) (full text)
- 72-hour monitoring and the medication washout: Cherian et al. 2024, Nat Med 30(2):373-381 (full text)
- CYP2D6 genotyping and dose reduction: Glue et al. 2015, J Clin Pharmacol 55(6):680-687 (doi)
- On-site physicians, IV fluids and electrolytes at a residential clinic: Davis et al. 2017, J Psychedelic Stud 1(2):65-73 (full text)
- Ibogaine plus psychotherapy, abstinence durations: Schenberg et al. 2014, J Psychopharmacol 28(11):993-1000 (abstract)
- Approved medications for opioid use disorder: US Food and Drug Administration
Wondering if ibogaine fits your situation?
Six questions, two minutes. A straight answer, and we'll tell you honestly if it's no.